New drug cocktail shows promise against tough blood cancer
Disease control
Ongoing
This study tested a two-step drug combination for people newly diagnosed with mantle cell lymphoma, a type of blood cancer that is not curable with standard treatments. Twenty-three patients who were eligible for a stem cell transplant received rituximab and bendamustine followed…
Phase: PHASE2 • Sponsor: Christine Ryan • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC